Increased prevalence and mortality in undiagnosed celiac disease
A Rubio–Tapia, RA Kyle, EL Kaplan, DR Johnson… - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: The historical prevalence and long-term outcome of undiagnosed
celiac disease (CD) are unknown. We investigated the long-term outcome of undiagnosed …
celiac disease (CD) are unknown. We investigated the long-term outcome of undiagnosed …
Epidemiology, presentation, and diagnosis of celiac disease
B Lebwohl, A Rubio-Tapia - Gastroenterology, 2021 - Elsevier
The incidence of celiac disease is increasing, partly because of improved recognition of, and
testing for, the disease. The rise in incidence is also due to a real increase of this immune-…
testing for, the disease. The rise in incidence is also due to a real increase of this immune-…
[HTML][HTML] Severe spruelike enteropathy associated with olmesartan
A Rubio-Tapia, ML Herman, JF Ludvigsson… - Mayo clinic …, 2012 - Elsevier
Objective To report the response to discontinuation of olmesartan, an angiotensin II receptor
antagonist commonly prescribed for treatment of hypertension, in patients with unexplained …
antagonist commonly prescribed for treatment of hypertension, in patients with unexplained …
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet
A Rubio-Tapia, MW Rahim, JA See… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: Clinical response is typically observed in most adults with celiac disease (CD)
after treatment with a gluten-free diet (GFD). The rate of mucosal recovery is less certain. …
after treatment with a gluten-free diet (GFD). The rate of mucosal recovery is less certain. …
ACG clinical guidelines: diagnosis and management of celiac disease
A Rubio-Tapia, ID Hill, CP Kelly… - Official journal of the …, 2013 - journals.lww.com
This guideline presents recommendations for the diagnosis and management of patients
with celiac disease. Celiac disease is an immune-based reaction to dietary gluten (storage …
with celiac disease. Celiac disease is an immune-based reaction to dietary gluten (storage …
The prevalence of celiac disease in the United States
A Rubio-Tapia, JF Ludvigsson… - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: The prevalence of celiac disease (CD) in the United States is unknown. We
sought to estimate CD prevalence nationwide by using a nationally representative sample. …
sought to estimate CD prevalence nationwide by using a nationally representative sample. …
Classification and management of refractory coeliac disease
A Rubio-Tapia, JA Murray - Gut, 2010 - gut.bmj.com
Refractory coeliac disease (RCD) is defined by persistent or recurrent malabsorptive symptoms
and villous atrophy despite strict adherence to a gluten-free diet (GFD) for at least 6–12 …
and villous atrophy despite strict adherence to a gluten-free diet (GFD) for at least 6–12 …
Increasing incidence of celiac disease in a North American population
JF Ludvigsson, A Rubio-Tapia… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: The prevalence of celiac disease (CD) varies greatly, potentially because of
incomplete ascertainment of cases and small study samples with limited statistical power. …
incomplete ascertainment of cases and small study samples with limited statistical power. …
American College of Gastroenterology guidelines update: diagnosis and management of celiac disease
A Rubio-Tapia, ID Hill, C Semrad… - Official journal of the …, 2023 - journals.lww.com
This guideline presents an update to the 2013 American College of Gastroenterology Guideline
on the Diagnosis and Management of Celiac Disease with updated recommendations …
on the Diagnosis and Management of Celiac Disease with updated recommendations …
Influence of gender on the clinical presentation and associated diseases in adults with celiac disease
A Rubio-Tapia, CL Jansson-Knodell… - Gaceta medica de …, 2016 - medigraphic.com
Introduction: Celiac disease is diagnosed predominantly in women. Objectives: We
investigated the influence of gender on (i) age at diagnosis,(ii) clinical manifestations, and (iii) …
investigated the influence of gender on (i) age at diagnosis,(ii) clinical manifestations, and (iii) …